You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
斯瑞新材(688102.SH):研發製造的CT和DR球管零組件產品是醫療影像設備中的重要零部件
格隆匯 04-07 16:36

格隆匯4月7日丨斯瑞新材(688102.SH)在投資者互動平台表示,公司研發製造的CT和DR球管零組件所在的“年產3萬套醫療影像裝備等電真空用材料、零組件研發及產業化項目”已於2025年4月3日收到上海證券交易所出具的《關於受理陝西斯瑞新材料股份有限公司科創板上市公司發行證券申請的通知》。公司研發製造的CT和DR球管零組件產品是醫療影像設備中的重要零部件,包括管殼組件、轉子組件、軸承套、陰極零件等。 基於醫療產業鏈對產品的嚴苛要求,公司集成自身的金屬材料、高精度加工、高超淨間真空釺焊、表面處理等多項技術,為客户持續提供高標準的產品。 2021年、2022年、2023年及2024年1-9月公司CT和DR球管零組件實現營業收入分別為2,641.33萬元、3,989.01萬元、4,832.94萬元及4,414.71萬元。公司該產品的主要客户目前有西門子醫療、聯影醫療、崑山醫源等。同時,公司與部分客户形成了戰略合作關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account